MiniMed's Model 508
This article was originally published in The Gray Sheet
Next-generation insulin infusion pump for diabetics, introduced Oct. 4, offers remote programming capabilities to administer or suspend insulin delivery and the capability to program multiple patient-specific delivery patterns. The device gained FDA 510(k) clearance in June
You may also be interested in...
Expanded roll-out of MiniMed's continuous glucose monitor system to twenty-one additional U.S. centers will be completed by the end of November, the firm says.
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.